ImportRefusal LogoImportRefusal

Azbil Corporationsinagawa Seaside South Tower

⚠️ Moderate Risk

FEI: 3010641365 • Shinagawa-ku, Tokyo-to • JAPAN

FEI

FEI Number

3010641365

📍

Location

Shinagawa-ku, Tokyo-to

🇯🇵

Country

JAPAN
🏢

Address

4 12 1 Higashishinagawa, , Shinagawa-ku, Tokyo-to, Japan

Moderate Risk

FDA Import Risk Assessment

32.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
1
Unique Violations
7/10/2014
Latest Refusal
7/10/2014
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

471×

NON STD

The article is subject to refusal of admission pursuant to section 536(a) of the Federal Food, Drug, and Cosmetic Act (FFDCA) in that it appears to be an electronic product offered for importation into the United States which fails to comply with an applicable standard prescribed pursuant to section 534 of the FFDCA.

Refusal History

DateProductViolationsDivision
7/10/2014
95RDWGENERAL PURPOSE LASER PRODUCTS, NON-MEDICAL
47NON STD
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Azbil Corporationsinagawa Seaside South Tower's FDA import refusal history?

Azbil Corporationsinagawa Seaside South Tower (FEI: 3010641365) has 1 FDA import refusal record(s) in our database, spanning from 7/10/2014 to 7/10/2014.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Azbil Corporationsinagawa Seaside South Tower's FEI number is 3010641365.

What types of violations has Azbil Corporationsinagawa Seaside South Tower received?

Azbil Corporationsinagawa Seaside South Tower has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Azbil Corporationsinagawa Seaside South Tower come from?

All FDA import refusal data for Azbil Corporationsinagawa Seaside South Tower is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.